• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

4
results for

"Jihye Park"

Filter

Article category

Keywords

Publication year

Authors

"Jihye Park"

Original Article

Accuracy of Ultrasound-Guided and Non-guided Botulinum Toxin Injection Into Neck Muscles Involved in Cervical Dystonia: A Cadaveric Study
Yun Dam Ko, Soo In Yun, Dahye Ryoo, Myung Eun Chung, Jihye Park
Ann Rehabil Med 2020;44(5):370-377.   Published online September 28, 2020
DOI: https://doi.org/10.5535/arm.19211
Objective
To compare the accuracy of ultrasound-guided and non-guided botulinum toxin injections into the neck muscles involved in cervical dystonia.
Methods
Two physicians examined six muscles (sternocleidomastoid, upper trapezius, levator scapulae, splenius capitis, scalenus anterior, and scalenus medius) from six fresh cadavers. Each physician injected ultrasound-guided and non-guided injections to each side of the cadaver’s neck muscles, respectively. Each physician then dissected the other physician’s injected muscle to identify the injection results. For each injection technique, different colored dyes were used. Dissection was performed to identify the results of the injections. The muscles were divided into two groups based on the difficulty of access: sternocleidomastoid and upper trapezius muscles (group A) and the levator scapulae, splenius capitis, scalenus anterior, and scalenus medius muscles (group B).
Results
The ultrasound-guided and non-guided injection accuracies of the group B muscles were 95.8% and 54.2%, respectively (p<0.001), while the ultrasound-guided and non-guided injection accuracies of the group A muscles were 100% and 79.2%, respectively (p<0.05).
Conclusion
Ultrasound-guided botulinum toxin injections into inaccessible neck muscles provide a higher degree of accuracy than non-guided injections. It may also be desirable to consider performing ultrasound-guided injections into accessible neck muscles.

Citations

Citations to this article as recorded by  
  • Optimal target localization for botulinum toxin A in treating splenius muscles dystonia based on the distribution of intramuscular nerves and spindles
    Xiaojiao He, Sifeng Wen, Xuan Liu, Yutong Li, Shengbo Yang
    Anatomical Science International.2026; 101(1): 44.     CrossRef
  • Ultrasound Guidance for Botulinum Toxin Injection of Muscles Innervated by the Facial Nerve: A Systematic Review of Anatomical Precision, Safety, and Outcomes
    Raisa Chowdhury, Benjamin Schiff, Yan H Lee, Suresh Mohan
    Aesthetic Surgery Journal.2026; 46(2): 195.     CrossRef
  • Ultrasound-guided injection of ankle contouring with botulinum neurotoxin
    Kyu-Ho Yi, Jin-Hyun Kim, Jong-Keun Song, Jeremy B. Green, Thomas Rappl, Michael H. Gold, Jeongho Sohn, Benjamin Ascher, Roya Zarmehr Zamin, Rosa Sigrist, Ximena Wortsman
    JPRAS Open.2026; 48: 425.     CrossRef
  • Efficacy and Safety of Botulinum Toxin Type A Injection for Trapezius Muscle Contouring: A Systematic Review
    Krishan Mohan Kapoor, Anmol Batra, Amrit Kaur, Aanandita Kapoor, Tim Papadopoulos
    International Journal of Aesthetic Plastic Surgery.2025; 1(1): 76.     CrossRef
  • Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review
    Hristo Shipkov, Petar Uchikov, Abdulrahman Imran, Zain Ul Hassan, Ivan Grozdev, Krasimir Kraev, Maria Kraeva, Nina Koleva, Maria Bozhkova, Stanislav Karamitev
    Life.2025; 15(6): 920.     CrossRef
  • Localization modalities for botulinum neurotoxin injection
    Barbara Illowsky Karp, Ann Ly, Katharine E. Alter
    Toxicon.2025; 264: 108460.     CrossRef
  • Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia
    Jarosław Sławek, Iga Alicja Łobińska, Michał Schinwelski, Joanna Kopcewicz-Wiśniewska, Anna Castagna
    Toxins.2025; 17(8): 375.     CrossRef
  • Comparison of Guided and Unguided Botulinum Injections for Cervical Dystonia: EMG, Ultrasound, and Anatomic Landmarks
    Vered Livneh, Achinoam Faust-Socher, Mikhal E. Cohen, Yosef Shechter, Ilana Israel, Roni Eichel, Tanya Gurevich, Gilad Yahalom
    CNS & Neurological Disorders - Drug Targets.2025; 24(7): 546.     CrossRef
  • Botulinum Toxin for Isolated or Essential Head Tremor

    New England Journal of Medicine.2024; 390(4): 383.     CrossRef
  • Current use of neurotoxins for alleviating symptoms of cervical dystonia
    Stephen Aradi, Robert A. Hauser
    Expert Review of Neurotherapeutics.2024; 24(8): 787.     CrossRef
  • Surface anatomy and levator scapulae muscle injection: A cadaveric investigation
    So-Youn Chang, Hee Young Lim, Sang-Hyun Kim, Jung-Woo Choi, Yong-Seok Nam, Jong In Lee
    Medicine.2024; 103(25): e38598.     CrossRef
  • Enhancing Botulinum Toxin Injection Precision: The Efficacy of a Single Cadaveric Ultrasound Training Intervention for Improved Anatomical Localization
    Camille Heslot, Omar Khan, Alexis Schnitzler, Chloe Haldane, Romain David, Rajiv Reebye
    Toxins.2024; 16(7): 304.     CrossRef
  • A Bayesian Network Meta-Analysis and Systematic Review of Guidance Techniques in Botulinum Toxin Injections and Their Hierarchy in the Treatment of Limb Spasticity
    Evridiki Asimakidou, Christos Sidiropoulos
    Toxins.2023; 15(4): 256.     CrossRef
  • Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review
    Roberto Erro, Marina Picillo, Maria Teresa Pellecchia, Paolo Barone
    Toxins.2023; 15(6): 391.     CrossRef
  • Muscle Ultrasound in Clinical Neurology: Diagnostic Uses and Guidance of Botulinum Toxin Injection
    Uwe Walter
    Journal of Neurosonology and Neuroimaging.2023; 15(1): 38.     CrossRef
  • In-Plane Ultrasound-Guided Botulinum Toxin Injection to Lumbrical and Interosseus Upper Limb Muscles: Technical Report
    Alexandros Toliopoulos
    Cureus.2023;[Epub]     CrossRef
  • Shoulder Spasticity Treatment With Botulinum Toxin: A Nationwide Cross-Sectional Survey of Clinical Practices
    Sérgio Pinho, Alexandre Camões-Barbosa, Madjer Hatia, Frederico Moeda, Xavier Melo, João Tocha
    Cureus.2023;[Epub]     CrossRef
  • Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?
    A. Kreisler, S. Djelad, C. Simonin, G. Baille, E. Mutez, A. Degardin, L. Defebvre, J. Labreuche, E. Cailliau, A. Duhamel
    Revue Neurologique.2022; 178(6): 591.     CrossRef
  • Morphological characteristics of the posterior neck muscles and anatomical landmarks for botulinum toxin injections
    Bilge İpek Torun, Simel Kendir, Luis Filgueira, R. Shane Tubbs, Aysun Uz
    Surgical and Radiologic Anatomy.2021; 43(8): 1235.     CrossRef
  • Ultrasound and Electromyography as Guidance Tools for the Botulinum Toxin Therapy in Cervical Dystonia
    G. Salazar, S. Ferreiro, M. Fragoso, J. Codas, H. Cruz
    Journal of Behavioral and Brain Science.2021; 11(02): 49.     CrossRef
  • The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
    Urban M. Fietzek, Devavrat Nene, Axel Schramm, Silke Appel-Cresswell, Zuzana Košutzká, Uwe Walter, Jörg Wissel, Steffen Berweck, Sylvain Chouinard, Tobias Bäumer
    Toxins.2021; 13(5): 365.     CrossRef
  • Novel approaches to the treatment of cervical dystonia. The concept of dual navigation control
    A. P. Kovalenko, Z. A. Zalyalova, A. F. Ivolgin
    Neurology, Neuropsychiatry, Psychosomatics.2021; 13(6): 124.     CrossRef
  • 11,589 View
  • 283 Download
  • 22 Web of Science
  • 22 Crossref

Corrigendum

Correction: Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection
Yongjun Jang, Geun-Young Park, Jihye Park, Asayeon Choi, Soo Yeon Kim, Chris Boulias, Chetan P. Phadke, Farooq Ismail, Sun Im
Ann Rehabil Med 2016;40(3):556-556.   Published online June 29, 2016
DOI: https://doi.org/10.5535/arm.2016.40.3.556
Corrects: Ann Rehabil Med 2016;40(2):279
  • 4,683 View
  • 35 Download

Original Article

Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection
Yongjun Jang, Geun-Young Park, Jihye Park, Asayeon Choi, Soo Yeon Kim, Chris Boulias, Chetan P. Phadke, Farooq Ismail, Sun Im
Ann Rehabil Med 2016;40(2):279-287.   Published online April 25, 2016
DOI: https://doi.org/10.5535/arm.2016.40.2.279
Correction in: Ann Rehabil Med 2016;40(3):556
Objective

To evaluate Korean physiatrists' practice of performing intramuscular botulinum toxin injection in anticoagulated patients and to assess their preference in controlling the bleeding risk before injection.

Methods

As part of an international collaboration survey study, a questionnaire survey was administered to 100 Korean physiatrists. Physiatrists were asked about their level of experience with botulinum toxin injection, the safe international normalized ratio range in anticoagulated patients undergoing injection, their tendency for injecting into deep muscles, and their experience of bleeding complications.

Results

International normalized ratio <2.0 was perceived as an ideal range for performing Botulinum toxin injection by 41% of the respondents. Thirty-six respondents replied that the international normalized ratio should be lowered to sub-therapeutic levels before injection, and 18% of the respondents reported that anticoagulants should be intentionally withheld and discontinued prior to injection. In addition, 20%–30% of the respondents answered that they were uncertain whether they should perform the injection regardless of the international normalized ratio values. About 69% of the respondents replied that they did have any standardized protocols for performing botulinum toxin injection in patients using anticoagulants. Only 1 physiatrist replied that he had encountered a case of compartment syndrome.

Conclusion

In accordance with the lack of consensus in performing intramuscular botulinum toxin injection in anticoagulated patients, our survey shows a wide range of practices among many Korean physiatrists; they tend to avoid botulinum toxin injection in anticoagulated patients and are uncertain about how to approach these patients. The results of this study emphasize the need for formulating a proper international consensus on botulinum toxin injection management in anticoagulated patients.

Citations

Citations to this article as recorded by  
  • Dry Needling and Antithrombotic Drugs
    María Muñoz, Jan Dommerholt, Sara Pérez-Palomares, Pablo Herrero, Sandra Calvo, Massimiliano Valeriani
    Pain Research and Management.2022; 2022: 1.     CrossRef
  • Antihemorrhagic Properties of Therapeutic Botulinum Toxin in Experimental Mice
    Sowbarnika Ravichandran, Jerly Helan Mary Joseph, Shanmugaapriya Sellathamby, Mahesh Kandasamy
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Botulinum Toxin Injection and Electromyography in Patients Receiving Anticoagulants: A Systematic Review
    Yeow Leng Tan, Tze Chao Wee
    PM&R.2021; 13(8): 880.     CrossRef
  • Intravesical onabotulinumtoxinA injections in patients on antiplatelet and anticoagulation therapy
    Elsie E. Mensah, Bogdan Toia, Linh Nguyen, Rizwan Hamid, Mahreen Pakzad, Jeremy L. Ockrim, Roger Walker, Tamsin J. Greenwell, Tharani Nitkunan, Davendra Sharma, Jai H. Seth
    Neurourology and Urodynamics.2021; 40(7): 1829.     CrossRef
  • Management of antithrombotics for intramuscular injection of botulinum toxin for spasticity. A survey of real-life practice in France
    Ozoua Ble, Djamel Bensmail, Dominic Pérennou, Bernard Parratte, Pierre-Alain Joseph, François-Constant Boyer, Hugues Michelon, Thibaud Lansaman, Jonathan Levy
    Annals of Physical and Rehabilitation Medicine.2021; 64(6): 101467.     CrossRef
  • Challenges in the management of anticoagulated patients with focal spasticity
    Chris Boulias, Farooq Ismail, Chetan P. Phadke
    Toxicon.2020; 177: 93.     CrossRef
  • Safety of OnabotulinumtoxinA with Concomitant Antithrombotic Therapy in Patients with Muscle Spasticity: A Retrospective Pooled Analysis of Randomized Double-Blind Studies
    Rozalina Dimitrova, Lynn James, Chengcheng Liu, Amelia Orejudos, Irina Yushmanova, Mitchell F. Brin
    CNS Drugs.2020; 34(4): 433.     CrossRef
  • Botulinum toxin therapy in patients with oral anticoagulation: is it safe?
    Christoph Schrader, Markus Ebke, Fereshte Adib Saberi, Dirk Dressler
    Journal of Neural Transmission.2018; 125(2): 173.     CrossRef
  • A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity
    Chris Boulias, Farooq Ismail, Chetan P. Phadke, Stephen Bagg, Isabelle Bureau, Stephane Charest, Robert Chen, Albert Cheng, Karen Ethans, Milo Fink, Heather Finlayson, Sivakumar Gulasingam, Meiqi Guo, Muriel Haziza, Hossein Hosseini, Omar Khan, Michael La
    Archives of Physical Medicine and Rehabilitation.2018; 99(11): 2183.     CrossRef
  • Prevalence of Bleeding Complications Following Ultrasound‐Guided Botulinum Toxin Injections in Patients on Anticoagulation or Antiplatelet Therapy
    Jeffrey LaVallee, Regan Royer, Geoffrey Smith
    PM&R.2017; 9(12): 1217.     CrossRef
  • Patterns of botulinum toxin treatment for spasticity and bleeding complications in patients with thrombotic risk
    Chetan P. Phadke, Vivekanand Thanikachalam, Farooq Ismail, Chris Boulias
    Toxicon.2017; 138: 188.     CrossRef
  • 10,879 View
  • 64 Download
  • 11 Web of Science
  • 11 Crossref
Case Report
Churg-Strauss Syndrome as an Unusual Cause of Dysphagia: Case Report
Jihye Park, Sun Im, Su-Jin Moon, Geun-Young Park, Yongjun Jang, Yeonjin Kim
Ann Rehabil Med 2015;39(3):477-481.   Published online June 30, 2015
DOI: https://doi.org/10.5535/arm.2015.39.3.477

Systemic vasculitis is a rare disease, and the diagnosis is very difficult when patient shows atypical symptoms. We experienced an unusual case of dysphagia caused by Churg-Strauss syndrome with lower cranial nerve involvement. A 74-year-old man, with a past history of sinusitis, asthma, and hearing deficiency, was admitted to our department for evaluation of dysphagia. He also complained of recurrent bleeding of nasal cavities and esophagus. Brain magnetic resonance imaging did not show definite abnormality, and electrophysiologic findings were suggestive of mononeuritis multiplex. Dysphagia had not improved after conventional therapy. Biopsy of the nasal cavity showed extravascular eosinophilic infiltration. All these findings suggested a rare form of Churg-Strauss syndrome involving multiple lower cranial nerves. Dysphagia improved after steroid therapy.

Citations

Citations to this article as recorded by  
  • AGA Clinical Practice Update on Esophageal Dysfunction Due to Disordered Immunity and Infection: Expert Review
    Chanakyaram A. Reddy, Emily McGowan, Rena Yadlapati, Kathryn Peterson
    Clinical Gastroenterology and Hepatology.2024; 22(12): 2378.     CrossRef
  • Gastrointestinal and Hepatic Disease in Vasculitis
    Eric Anderson, Neel Gakhar, Courtney Stull, Liron Caplan
    Rheumatic Disease Clinics of North America.2018; 44(1): 1.     CrossRef
  • Head and Neck Manifestations of Eosinophilic Granulomatosis with Polyangiitis
    Jared M. Goldfarb, Mindy R. Rabinowitz, Shristi Basnyat, Gurston G. Nyquist, Marc R. Rosen
    Otolaryngology–Head and Neck Surgery.2016; 155(5): 771.     CrossRef
  • 6,653 View
  • 62 Download
  • 3 Web of Science
  • 3 Crossref
TOP